Bachier C - Search Results

1

Denileukin diftitox for the treatment of steroid-resistant acute graft-versus-host disease.

Shaughnessy PJ, Bachier C, Grimley M, Freytes CO, Callander NS, Essell JH, Flomenberg N, Selby G, Lemaistre CF. Shaughnessy PJ, et al. Among authors: bachier c. Biol Blood Marrow Transplant. 2005 Mar;11(3):188-93. doi: 10.1016/j.bbmt.2004.11.022. Biol Blood Marrow Transplant. 2005. PMID: 15744237 Free article. Clinical Trial.

2

Ex-vivo expansion of bone marrow progenitor cells for hematopoietic reconstitution following high-dose chemotherapy for breast cancer.

Bachier CR, Gokmen E, Teale J, Lanzkron S, Childs C, Franklin W, Shpall E, Douville J, Weber S, Muller T, Armstrong D, LeMaistre CF. Bachier CR, et al. Exp Hematol. 1999 Apr;27(4):615-23. doi: 10.1016/s0301-472x(98)00085-x. Exp Hematol. 1999. PMID: 10210319 Free article. Clinical Trial.

3

Ex vivo-expanded hematopoietic cell graft recipients exhibit T cell repertoire diversity similar to that seen after conventional stem cell transplants.

Gokmen E, Bachier C, Raaphorst FM, Muller T, Armstrong D, Lemaistre CF, Teale JM. Gokmen E, et al. Among authors: bachier c. J Hematother Stem Cell Res. 2001 Feb;10(1):53-66. doi: 10.1089/152581601750098237. J Hematother Stem Cell Res. 2001. PMID: 11276359 Review.

4

Graft failure in a patient with systemic lupus erythematosus (SLE) treated with high-dose immunosuppression and autologous stem cell rescue.

Shaughnessy PJ, Ririe DW, Ornstein DL, Kissack B, Bickford DJ, Molina R, Lanzkron S, Bachier C, Nanez A, LeMaistre CF. Shaughnessy PJ, et al. Among authors: bachier c. Bone Marrow Transplant. 2001 Jan;27(2):221-4. doi: 10.1038/sj.bmt.1702767. Bone Marrow Transplant. 2001. PMID: 11281396

5

Ig heavy chain CDR3 size diversities are similar after conventional peripheral blood and ex vivo expanded hematopoietic cell transplants.

Gokmen E, Bachier C, Raaphorst FM, Muller T, Armstrong D, LeMaistre CF, Teale JM. Gokmen E, et al. Among authors: bachier c. Bone Marrow Transplant. 2001 Feb;27(4):413-24. doi: 10.1038/sj.bmt.1702794. Bone Marrow Transplant. 2001. PMID: 11313671

6

A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation.

Pecora AL, Stiff P, LeMaistre CF, Bayer R, Bachier C, Goldberg SL, Parthasarathy M, Jennis AA, Smith AK, Douville J, Chen B, Armstrong RD, Mandalam RK, Preti R. Pecora AL, et al. Among authors: bachier c. Bone Marrow Transplant. 2001 Aug;28(3):295-303. doi: 10.1038/sj.bmt.1703137. Bone Marrow Transplant. 2001. PMID: 11535999 Clinical Trial.

7

Phase II study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience.

Shaughnessy PJ, Ornstein D, Ririe D, Callander N, Anderson JE, Pollack MS, Freytes CO, Cruz J, Rodriquez T, Bachier C, LeMaistre CF. Shaughnessy PJ, et al. Among authors: bachier c. Biol Blood Marrow Transplant. 2002;8(8):420-8. doi: 10.1053/bbmt.2002.v8.pm12234167. Biol Blood Marrow Transplant. 2002. PMID: 12234167 Free article. Clinical Trial.

8

Phase I and pharmacokinetic study of once-daily dosing of intravenously administered busulfan in the setting of a reduced-intensity preparative regimen and allogeneic hematopoietic stem cell transplantation as immunotherapy for renal cell carcinoma.

Shaughnessy P, Alexander W, Tran H, Ririe D, Splichal J, Pollack M, Bachier C, LeMaistre C. Shaughnessy P, et al. Among authors: bachier c. Mil Med. 2006 Feb;171(2):161-5. doi: 10.7205/milmed.171.2.161. Mil Med. 2006. PMID: 16578989 Clinical Trial.

9

Granulocyte colony-stimulating factor mobilizes more dendritic cell subsets than granulocyte-macrophage colony-stimulating factor with no polarization of dendritic cell subsets in normal donors.

Shaughnessy PJ, Bachier C, Lemaistre CF, Akay C, Pollock BH, Gazitt Y. Shaughnessy PJ, et al. Among authors: bachier c. Stem Cells. 2006 Jul;24(7):1789-97. doi: 10.1634/stemcells.2005-0492. Stem Cells. 2006. PMID: 16822885 Clinical Trial.

10

Endpoints for clinical trials testing treatment of acute graft-versus-host disease: a joint statement.

Martin PJ, Bachier CR, Klingemann HG, McCarthy PL, Szabolcs P, Uberti JP, Schuster MW, Weisdorf D, Chao NJ, Kebriaei P, Shpall EJ, Macmillan ML, Soiffer RJ. Martin PJ, et al. Biol Blood Marrow Transplant. 2009 Jul;15(7):777-84. doi: 10.1016/j.bbmt.2009.03.012. Epub 2009 May 13. Biol Blood Marrow Transplant. 2009. PMID: 19539208 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters